I t will probably come as no surprise that acne is one of the more common skin disorders out there. Most of us have either experienced it firsthand or know someone who has. While ...
Bimekizumab now has 5 US indications, including hidradenitis suppurativa, within 13 months, showcasing its therapeutic versatility. The BE HEARD I and BE HEARD II trials provided robust data ...
The drug survival for adalimumab is significantly higher than that of infliximab in pediatric patients with hidradenitis suppurativa (HS), results from a small single-center study showed.